BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14294237)

  • 41. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 42. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
    McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
    Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU.
    OSBORN SB; WALSHE JM
    Clin Sci; 1964 Apr; 26():213-7. PubMed ID: 14161054
    [No Abstract]   [Full Text] [Related]  

  • 45. Wilson's disease (hepatolenticular degeneration).
    Herron BE
    Ophthalmic Semin; 1976; 1(1):63-9. PubMed ID: 1023089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recent acquisitions in the study of Wilson's disease].
    Sternlieb I
    Rev Med Chir Mal Foie; 1965 Sep; 40(4):199-204. PubMed ID: 5851771
    [No Abstract]   [Full Text] [Related]  

  • 47. [CERULOPLASMIN CONTENT IN PATIENTS WITH HEPATOCEREBRAL DYSTROPHY AND IN THEIR HEALTHY RELATIVES].
    MITTELSHTEDT AA; BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():819-21. PubMed ID: 14235907
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
    Hoogenraad TU; Koevoet R; de Ruyter Korver EG
    Eur Neurol; 1979; 18(3):205-11. PubMed ID: 477692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Answer to challenging issues in the management of Wilson's disease.
    Poujois A; Woimant F
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):e7-e8. PubMed ID: 30166252
    [No Abstract]   [Full Text] [Related]  

  • 52. Elevated salivary copper concentration in patients with Wilson's disease.
    Bonilha PÁAM; Souza VC; Brandão I; Costa FS; Amaral CDB; Betini BG; Barbosa ER; Teive HAG
    Parkinsonism Relat Disord; 2023 Nov; 116():105893. PubMed ID: 37890335
    [No Abstract]   [Full Text] [Related]  

  • 53. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
    Haghighat M; Dehghani SM; Imanieh MH; Gholami S
    Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
    [No Abstract]   [Full Text] [Related]  

  • 54. A mathematical model for copper metabolism and its relation to Wilson's disease.
    Hazelrig JB; Owen CA; Ackerman E
    Am J Physiol; 1966 Nov; 211(5):1075-81. PubMed ID: 5924028
    [No Abstract]   [Full Text] [Related]  

  • 55. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of radiocopper in the diagnosis of Wilson's disease.
    Sternlieb I; Scheinberg IH
    Gastroenterology; 1979 Jul; 77(1):138-42. PubMed ID: 447011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper.
    MORELL AG; SCHEINBERG IH
    Science; 1958 Mar; 127(3298):588-90. PubMed ID: 13529022
    [No Abstract]   [Full Text] [Related]  

  • 59. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
    J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease?
    Diaz J; Acosta F; Cañizares F; Bueno FS; Tornel PL; Tovar I; Contreras RF; Marquez M; Martinez P; Parrilla P
    Transplant Proc; 1995 Aug; 27(4):2306. PubMed ID: 7652819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.